An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor
Clinical trial NCT01231568 · COMPLETED
Trial details
- NCT number
- NCT01231568
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-21
- Primary completion
- 2011-05-13
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.